NatureWise Biotech & Medicals Corporation (TPEX:4732)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.00
0.00 (0.00%)
May 8, 2026, 1:53 PM CST
Market Cap893.05M -10.4%
Revenue (ttm)176.77M -19.7%
Net Income-92.28M
EPS-1.89
Shares Out47.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,170
Average Volume50,854
Open18.90
Previous Close19.00
Day's Range18.90 - 19.00
52-Week Range18.55 - 27.85
Beta0.54
RSI42.93
Earnings DateMay 13, 2026

About TPEX:4732

NatureWise Biotech & Medicals Corporation engages in the research and development of Western medicine, Chinese medicine, and biotechnology in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and green propolis and red yeast rice products. The company was founded in 1990 and is headquartered in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 32
Stock Exchange Taipei Exchange
Ticker Symbol 4732
Full Company Profile

Financial Performance

In 2024, TPEX:4732's revenue was 224.32 million, an increase of 40.08% compared to the previous year's 160.14 million. Earnings were 897,000, a decrease of -91.14%.

Financial Statements